Some British patients are now traveling to the Netherlands for their cannabis medicine, where medical use is legal. Countries such as Germany and Denmark purchase Sativex, made by GW Pharmaceuticals, as pain and spasm relieving medicine. Sativex is a cannabis tincture that should be made more accessible to those in need.
Sarah is now the British representative for the the International Association of Cannabinoid Medicines (IACM) and recently delivered a presentation at a convention in Bonn, Germany. Her interest lies in ‘whole plant’ cannabis research and medical use.
Marijuana linked to preventing and treating Alzheimer’s disease
http://www.agoracosmopolitan.com/news/health/2011/11/26/1936.html
Americans for Safe Access also has links to research studies suggesting that cannabis may help in the treatment or prevention of Alzheimer’s disease and cancer, while the International Association for Cannabis as Medicine highlights the following medical uses
Alzheimer’s disease is the leading cause of dementia among the elderly, and with the ever-increasing size of this population, cases of Alzheimer’s disease are expected to triple over the next 50 years.
Dr. David Bearman presents “Cannabis and Cannabinoids in 21st Century Medicine: Medical Marijuana in the Clinic”.
Date: Nov. 13, 2007
Location: UW-Madison Medical School
David Bearman M.D., Santa Barbara, California, is one of the leading physicians in the U.S. in the field of medical marijuana. He has spent 40 years working in substance and drug abuse treatment and prevention programs. Dr. Bearman was a pioneer in the free and community clinic movement. His career includes public health, administrative medicine, primary care, pain management and cannabinology.
Medical Marijuana Inc. (OTC: MJNA) Marijuana Extract Cannabidiol (CBD) Possible Use As A Prevention And Treatment To Alzheimer’s Disease
MedicalMarijuanaInc
A Disease That affects 5.6 Million People And Costs $182 Billion Annually In The United States.Medical Marijuana Inc. Patent Pending Extraction Method Is Used To Isolate Cannabidiol From Marijuana Without Any Other Psychoactive Properties.
SAN DIEGO, CA–(Business Wire – Sept 6, 2011) – Medical Marijuana Inc (OTC: MJNA) is pleased to announce that studies have shown Cannabidiol (CBD) as a possible prevention and treatment for Alzheimer’s disease. Medical Marijuana Inc. through CannaBANK has a patent pending on an extraction method from Cannabis Sativa (Marijuana) and its industrialized non psychoactive counterpart Hemp, allowing Cannabidiol (CBD) to be isolated in its pure form. Read the rest of this entry »